- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
AARDEX Group Joins IT4Anxiety Project
AARDEX Group joins the IT4Anxiety Project [https://www.nweurope.eu/projects/project-search/it4anxiety-managing-anxiety-via-innovative-technologies-for-better-mental-health/] to support the implementation of innovative solutions to reduce anxiety of those living with neurodegenerative diseases or post-traumatic stress disorder (PTSD). AARDEX Group will enroll their tools and solutions that they used in clinical trials in this study to monitor medication adherence in daily clinical practice. Older adults living with dementia are impacted by non-adherence to medications. AARDEX Group will be able to observe how people interact with the solution to then be individualized for future service users. Vincoane de Moffarts, IT4Anxiety lead partner, commented that theseco-created innovative solutions will aim to be implemented to address the needs of this population.
Read more about this news release here.
